Massachusetts — Lanton Law Blog

Lanton Law Speaks With Pharmacy Times About Provider Status

Below is the description from Pharmacy Times about our discussion with them on pharmacy provider status. You can listen to the interview here.

CMS, healthcare, pharmaceuticals, pharmacyRon LantonOctober 6, 2023pharmacy, pharmacy provider status, collaborative agreement, reimbursement, New England, Massachusetts, Michigan

Lanton Law Talks Provider Status With Don Downing; Clinical Professor at the UW School of Pharmacy

We have a new podcast with Professor Downing of the University of Washington School of Pharmacy. We discuss pharmacy provider status and the opportunities within pharmacy.

pharmacy, healthcareRon LantonOctober 18, 2022pharmacy, pharmacy provider status, Washington State, Massachusetts

Massachusetts Attorney General Agrees to Optum Atrius Health Merger

Massachusetts Attorney General Healey has agreed to Optum’s Atrius Health acquisition for a price of $236 million. With this Optum has taken another step in its acquisition of Massachusetts’ largest independent physician organization.

health system, healthcare, insurance, pharmaceuticalsRon LantonApril 28, 2022Massachusetts, Attorney General, Optum, UnitedHealth, Atrius Health, Massachusetts Health Policy Commission

Massachusetts Discussing Data Privacy Protection

Senator Creem and Senator Lesser have introduced S.46 titled “An Act Establishing the Massachusetts Information Privacy Act.” The bill can be found here.

privacy, communications, data privacy, data broker, data, healthcare, biometricRon LantonMarch 16, 2022An Act Establishing the Massachusetts Information Privacy Act., Massachusetts, data privacy, data collection, data tracking, data broker, Biometrics, MA Information Privacy Commission

Massachusetts Launches First in the Nation Marijuana Product Catalog For Public Awareness of the Regulated Supply Chain

The Massachusetts Cannabis Control Commission has distributed a press release announcing the first in the nation of a “Product Catalog that will provide the public with a comprehensive database of regulated marijuana products that are sold through the Commonwealth’s licensed Medical Marijuana Treatment Centers (MTCs) and Marijuana Establishments (MEs). The regulatory platform, which is considered the first of its kind in the nation, is hosted through the state’s seed-to-sale system of record, Metrc, and will be embedded on the Commission’s website.”

marijuana, cannabis, CBD, healthcare, medical marijuana, pharmaceuticals, pharmacy, recreational marijuanaRon LantonApril 20, 2021Massachusetts Cannabis Control, Massachusetts, Massachusetts Marijuana Product Catalog, Cannabis

Massachusetts Enacts New Climate Law

This month, Governor Baker (R-MA) signed SB 9 titled “An Act Creating a Next Generation Roadmap for Massachusetts Climate Policy.”

Clean Energy, Green Energy, offshore windRon LantonMarch 31, 2021Green Energy, Massachusetts Climate Policy, energy efficient building codes, emissions, Environmental Justice Communities, offshore wind energy, Massachusetts

Lanton Law Interviews the Massachusetts Pharmacists Association on DIR & Provider Status

We are excited to have Lindsay De Santis; Executive Vice President of the Massachusetts Pharmacists Association (MPhA) do a blogcast with us. Our conversation covers pharmacy DIR (direct and indirect remuneration) fees, pharmacy provider status and COVID-19.

life sciences, pharmaceuticals, pharmacy, reimbursement, Medicare Part B, Medicare Part DRon LantonMay 19, 2020DIR fee, DIR, direct and indirect remuneration fees, pharmacy provider status, provider status, COVID-19, Massachusetts, Massachusetts Pharmacists Association